Ilia Zhidkov - 18 Mar 2026 Form 3 Insider Report for Evogene Ltd. (EVGN)

Role
Chief Technology Officer
Signature
/s/ Nitsan Deutsch, attorney-in-fact
Issuer symbol
EVGN
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 08:16:09 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Zhidkov Ilia Chief Technology Officer 19 EGOZ ST., ASHDOD, ISRAEL /s/ Nitsan Deutsch, attorney-in-fact 18 Mar 2026 0002085018

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding EVGN Stock Option (right to buy ordinary shares) 18 Mar 2026 Ordinary shares 3,000 $49.47 Direct
holding EVGN Stock Option (right to buy ordinary shares) 18 Mar 2026 Ordinary shares 750 $15.60 Direct
holding EVGN Stock Option (right to buy ordinary shares) 18 Mar 2026 Ordinary shares 8,000 $28.63 Direct
holding EVGN Stock Option (right to buy ordinary shares) 18 Mar 2026 Ordinary shares 6,000 $7.74 Direct F1
holding EVGN Stock Option (right to buy ordinary shares) 18 Mar 2026 Ordinary shares 40,000 $2.30 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options reported in this row were granted to the Reporting Person on March 8, 2023 and vest and become exercisable on an equal, quarterly basis (6.25% per quarter) over a four-year period such that they will be fully vested on the four-year anniversary of the grant date.
F2 The options reported in this row were granted to the Reporting Person on November 20, 2024 and vest and become exercisable on an equal, quarterly basis (6.25% per quarter) over a four-year period such that they will be fully vested on the four-year anniversary of the grant date.

Remarks:

Exhibit 24.1 - Power of Attorney.